This second episode in the series discusses the activities of the External Education FAWG and the different learning opportunities that are currently available and coming soon to all MAPS members.
This article provides top-level framework and broad conceptual categories for understanding digital structures within Medical Affairs and biopharmaceutical/MedTech organizations, helping leaders to make organizational decisions to drive their digital strategy with intention and purpose.
In this episode of the Elevate podcast series, MAPS speaks with experts about tackling the challenges of an expanding world and understanding who is communicating research by measuring Share of Voice.
In this webinar, we will discover how Medical Affairs teams are evolving from an executional hub to a strategic pillar, resonating and reconciling the voice of the patient and clinicians, and driving insights to their organization.
This White Paper provides a foundational understanding of insights management, including the definition and value of insights, processes and technologies for insights management, and key challenges in implementation.
In this webinar, we aim to gather insights from expert speakers who will cover practical lived examples of navigating the landscape, cross functional partnership for effective results, challenges that still persist, and future implications addressing the need to establish global guidelines. Perspectives from GPP guidelines, industry/patient experience, and from publishers will be the main focus.
This webinar provides multiple perspectives from both both industry and agency partners, examining how to ensure alignment on needs, goals, and mutual accountability, as well as defining what a “best” partner looks like.
In this our third episode this season, we’ll be discussing how and why medical publishing is changing and where is it going in the future.
In this webinar, a roundtable of experienced Medical Affairs leaders will discuss the opportunities and challenges evolving within their field, as well as the impact it can have on delivering great patient outcomes.
With a multibillion dollar investment from Microsoft and already 4 authorship credits on PubMed, ChatGPT is poised to disrupt Medical Affairs.